Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept for Scalp Psoriasis
NCT00791765Phase 4Completed
- Sponsor
- Amgen
- Start
- Oct 2008
- Primary completion
- Jan 2010
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 4 trial of etanercept in plaque psoriasis, sponsored by Amgen. Started Oct 2008; status: completed.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00791765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00791765.